AI Article Synopsis
Article Abstract
Background: Bacillus probiotics health benefits have been until now quite poorly studied in the elderly population. This study aimed to assess the effects of Bacillus subtilis CU1 consumption on immune stimulation and resistance to common infectious disease (CID) episodes in healthy free-living seniors.
Results: One hundred subjects aged 60-74 were included in this randomized, double-blind, placebo-controlled, parallel-arms study. Subjects consumed either the placebo or the probiotic (2.10(9) B. subtilis CU1 spores daily) by short periodical courses of 10 days intermittently, alternating 18-day course of break. This scheme was repeated 4 times during the study. Symptoms of gastrointestinal and upper/lower respiratory tract infections were recorded daily by the subjects throughout the study (4 months). Blood, saliva and stool samples were collected in a predefined subset of the first forty-four subjects enrolled in the study. B. subtilis CU1 supplementation did not statistically significantly decrease the mean number of days of reported CID symptoms over the 4-month of study (probiotic group: 5.1 (7.0) d, placebo group: 6.6 (7.3) d, P = 0.2015). However, in the subset of forty-four randomized subjects providing biological samples, we showed that consumption of B. subtilis CU1 significantly increased fecal and salivary secretory IgA concentrations compared to the placebo. A post-hoc analysis on this subset showed a decreased frequency of respiratory infections in the probiotc group compared to the placebo group.
Conclusion: Taken together, our study provides evidence that B. subtilis CU1 supplementation during the winter period may be a safe effective way to stimulate immune responses in elderly subjects.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669646 | PMC |
| http://dx.doi.org/10.1186/s12979-015-0051-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The probiotic strain Bacillus subtilis CU1 primes antimicrobial innate immune response and reduces low-grade inflammation: a clinical study.
Benef Microbes
August 2024
Gnosis by Lesaffre - Research & Applications department, Lesaffre Group, Marcq-en-Baroeul, France.
Article Synopsis
- The clinical study investigated the effects of LifeinU™ Bacillus subtilis CU1 (BSCU1) on immune responses in 88 participants across different age groups, aiming to understand how it might improve protection against infections.
- Although BSCU1 did not significantly alter fecal sIgA levels, it positively impacted various markers of the innate immune system, especially in adults and the elderly, by increasing peripheral blood myeloid cells and CD69 expression on monocytes.
- Additionally, the supplementation led to higher production of pro-inflammatory cytokines and improved the ability of monocytes to engulf bacteria, while also reducing levels of certain inflammatory cytokines in older adults, suggesting potential benefits for overall immune health.
In vitro and in vivo activity of new strains of Bacillus subtilis against ESBL-producing Escherichia coli: an experimental study.
J Appl Microbiol
March 2022
MiHAR Lab, EE1701, University of Nantes, Nantes, France.
Aims: The gastro-intestinal tract is a major reservoir of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. Bacillus spores may be used as probiotics to decrease digestive colonization by ESBL-E. coli.
View Article and Find Full Text PDFEffect of CNCM-I 3799 and CU-1 on Acute Watery Diarrhea: A Randomized Double-Blind Placebo-Controlled Study in Indian Children.
Pediatr Gastroenterol Hepatol Nutr
September 2021
Department of Pediatrics, Institute of Child Health, Kolkata, India.
Purpose: To assess the effect of combination probiotic CNCM-I 3799 and CU-1 in outpatient management of acute watery diarrhea in children.
Methods: A randomized double-blind placebo-controlled study was conducted in 180 participants aged six months to five years with acute mild to moderate diarrhea. All were enrolled from six centers across India and centrally randomized to receive CNCM-I 3799 and CU-1 or a placebo along with oral rehydration salts and zinc supplementation.
Probiotics for the Prevention of Acute Respiratory-Tract Infections in Older People: Systematic Review.
Healthcare (Basel)
June 2021
Faculty of Health Sciences, Institute for Health and Nutrition, University of Maribor, Žitna ulica 15, 2000 Maribor, Slovenia.
The aim of this systematic review was to present the indirect influence of probiotics on the incidence and duration of acute upper respiratory-tract infections in older people, by regulating the immune system. Eight randomized, placebo-controlled clinical trials met the inclusion criteria, considering the threshold of older people being 60 years and over. Single strain probiotics were used in all studies, including three probiotic strains used in fermented foods: subsp.
View Article and Find Full Text PDFAntidiarrheal Action of CU1 CNCM I-2745 and CNCM I-4547 in Mice.
Front Microbiol
July 2018
Neuro-Gastroenterology and Nutrition Unit, INRA, Toulouse, France.
Preventive actions of probiotics as antidiarrheal agents are well documented, but their mechanisms are poorly understood. Two selected probiotics, CU1 and CNCM I-4547, were tested in mouse experimental models of diarrhea and the possible mechanisms of action were investigated. Diarrhea was induced in mice by oral castor oil administration or by i.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!